Table 1 Association between BCAR4 expression and the clinicopathological parameters of breast cancer patients (all female)
| Â | BCAR4 expression | Â | |
|---|---|---|---|
Clinical parameters | Low (n = 40) | High (n = 40) | P value |
Age | |||
 ≤ 50 | 14 | 17 | 0.491 |
 >50 | 26 | 23 |  |
Tumor size | |||
 ≤ 3 cm | 29 | 19 | 0.041 |
 >3 cm | 11 | 21 |  |
TNM stage | |||
 I–II | 28 | 2 | 0.000 |
 III–IV | 12 | 38 |  |
LN metastasis | |||
 Yes | 15 | 28 | 0.004 |
 No | 25 | 12 |  |
ER status | |||
 Positive | 16 | 18 | 0.651 |
 Negative | 24 | 22 |  |
PR status | |||
 Positive | 18 | 25 | 0.116 |
 Negative | 22 | 15 |  |
HER2 status | |||
 Positive | 20 | 22 | 0.654 |
 Negative | 20 | 18 |  |
Molecular subtype | |||
 Luminal A | 16 | 12 | 0.446 |
 Luminal B | 9 | 10 |  |
 HER2 +  | 13 | 12 |  |
 Basal-like | 2 | 6 |  |